Supplement Firms Confounded By Identity Testing Waiver Process
This article was originally published in The Tan Sheet
Executive Summary
FDA says it has not received any petitions to request an exemption from the 100% supplement ingredient identity testing requirement. Food and drug attorneys say the hassle of preparing a petition for a waiver outweighs the potential benefits
You may also be interested in...
Industry News Roundup
Acetaminophen skin reacting warning in draft guidance; supplement ingredient testing exemption option continues; FTC breaks Habitrol from GSK/Novartis JV; NARB stops clock on Mucinex 8-minute claim; kick start for ClickStick; NVC drinks up Blu-Dot; drug claims, GMP problems for Avena Botanicals; Ugam beefs up MusclePharm price monitoring; Nutraceutical International growth trims income; SDC Nutrition on global mission; and Naturally Splendid acquires Full Spectrum technology.
Industry News Roundup
Acetaminophen skin reacting warning in draft guidance; supplement ingredient testing exemption option continues; FTC breaks Habitrol from GSK/Novartis JV; NARB stops clock on Mucinex 8-minute claim; kick start for ClickStick; NVC drinks up Blu-Dot; drug claims, GMP problems for Avena Botanicals; Ugam beefs up MusclePharm price monitoring; Nutraceutical International growth trims income; SDC Nutrition on global mission; and Naturally Splendid acquires Full Spectrum technology.
First GMP Warning Letter Reflects FDA's List Of Major Concerns
FDA's first warning letter concerning dietary supplement good manufacturing practices advises Coats International Holdings to follow written procedures, improve documentation and conduct appropriate identity tests